Similar articles

• Human recombinant hemopoietic growth factors G-CSF and GM-CSF: first results of clinical trials.

  Nissen-Druey C. Nissen-Druey C. Nouv Rev Fr Hematol (1978). 1989;31(2):99-101. Nouv Rev Fr Hematol (1978). 1989. PMID: 2475852 Review. No abstract available.
• Colony-stimulating factors: clinical status.

  Gabrilove JL. Gabrilove JL. Important Adv Oncol. 1991:215-37. Important Adv Oncol. 1991. PMID: 1714420 Review. No abstract available.
• [Rational therapy with G-CSF and GM-CSF].

  Link H, Herrmann F, Welte K, Aulitzky WE, Ganser A, Kern WV, Meyer P, Schrappe M, Schmoll HJ, Werdan K, et al. Link H, et al. Med Klin (Munich). 1994 Aug 15;89(8):429-41. Med Klin (Munich). 1994. PMID: 7526144 Review. German. No abstract available.
• The impact of myeloid growth factors on engraftment following autologous bone marrow transplantation for malignant lymphoma.

  Rabinowe SN, Nemunaitis J, Armitage J, Nadler LM. Rabinowe SN, et al. Semin Hematol. 1991 Apr;28(2 Suppl 2):6-16. Semin Hematol. 1991. PMID: 1712125 Review. No abstract available.
• Clinical applications of human granulocyte-macrophage colony-stimulating factor.

  Sakamoto KM, Gasson JC. Sakamoto KM, et al. Int J Cell Cloning. 1991 Nov;9(6):531-41. doi: 10.1002/stem.5530090603. Int J Cell Cloning. 1991. PMID: 1770227 Review.